A food allergic reaction unfolds as a chain of immune events, not a single moment of crisis. While the visible symptoms may appear within minutes, the underlying process stretches across distinct phases, from an initial period of immune sensitization that can happen weeks or months before the first reaction, through mast cell arming, rapid mediator release, a slower inflammatory wave, and sometimes a delayed second flare hours later. Understanding each stage helps explain why allergic reactions vary so much in timing, severity, and response to treatment.
Stage One: Sensitization
The whole sequence begins long before you ever feel a symptom. In sensitization, your immune system encounters a food protein for the first time and, instead of ignoring it, labels it as dangerous. Normally, immune cells in the gut promote tolerance to food proteins, recognizing them as harmless. But under certain conditions, this tolerance process breaks down. Immune cells called dendritic cells in the skin, gut, or lungs can promote allergic sensitization when activated by inflammatory signals, such as stress molecules called alarmins or disruptions in gut bacteria.1Journal of Allergy and Clinical Immunology. Dendritic cells in food allergy, treatment, and tolerance
Once these immune cells flag a food protein as a threat, the body produces IgE antibodies specific to that protein. You can eat the food dozens of times before sensitization happens, or it can occur on one of the earliest exposures. The crucial point is that sensitization itself produces no symptoms. You feel perfectly fine. The immune system has simply drawn up a battle plan against a protein that poses no real danger, and it is waiting for the next encounter.
Where you first encounter the allergen matters more than researchers initially thought. The dual allergen exposure hypothesis proposes that eating a food protein tends to promote tolerance, while encountering that same protein through inflamed skin tends to cause allergic sensitization.2PubMed Central. Skin and oral intervention for food allergy prevention based on dual allergen exposure hypothesis This is one reason children with eczema have higher rates of food allergy: allergens in household dust can enter through their damaged skin barrier, priming the immune system before the child ever eats that food. Peanut allergens in particular have been measured in household dust, and applying food proteins to impaired skin in mice leads to IgE production and later anaphylaxis upon eating.3PubMed Central. The airway as a route of sensitization to peanut: An update to the dual allergen exposure hypothesis Still, only about a third of children with eczema go on to develop a food allergy, so additional factors beyond skin exposure are clearly involved.4PubMed. The riddle of response to cutaneous allergen exposure in patients with atopic dermatitis
Stage Two: Arming the Mast Cells
After sensitization, those newly minted IgE antibodies circulate through the blood and attach to receptors on mast cells, which are immune cells stationed throughout your skin, gut lining, and airways. The receptor they latch onto, called FcεRI, binds IgE with extremely high affinity, meaning once IgE locks on, it stays put for weeks or months.5PubMed Central. FcεRI: A Master Regulator of Mast Cell Functions Think of it as loading a trigger: the mast cell is now “armed” and waiting for the specific food protein it was sensitized to.
This stage, like sensitization, is invisible. You carry these armed mast cells around with no discomfort. A blood test might show elevated IgE to a particular food, but that alone does not guarantee you will react. Some people have measurable IgE to a food and tolerate it without issue. The clinical reaction only happens when the next stage kicks in.
Stage Three: The Early-Phase Reaction
The moment you eat the offending food again, allergen molecules cross the gut lining and encounter those armed mast cells. When two IgE molecules sitting on the same mast cell are bridged by a single allergen molecule, the mast cell degranulates, dumping its preloaded cargo within seconds. That cargo includes histamine, prostaglandins, leukotrienes, and other chemical mediators.6Nature Communications. PGD2 deficiency exacerbates food antigen-induced mast cell hyperplasia This rapid release is what makes food allergies feel so sudden. One bite and, within minutes, you might feel your lips tingling, your throat tightening, or hives spreading across your skin.
Histamine is the most well-known of these mediators, responsible for swelling, itching, and blood vessel dilation. But it is far from the only player. Mast cells also release prostaglandin D2, which researchers have shown increases in urine samples of food allergy model mice during reactions, driven by specific enzyme pathways activated during the allergic response.7PubMed Central. Prostaglandin D2 metabolite in urine is an index of food allergy The sheer variety of these mediators explains why antihistamines alone often cannot fully control a serious reaction: histamine is only one piece of a much larger chemical storm.
Symptoms in this phase vary enormously from person to person and even from one reaction to the next in the same individual. Mild early-phase reactions might involve a few hives, some stomach cramping, or a runny nose. Severe ones can include throat swelling, a dangerous drop in blood pressure, difficulty breathing, and full anaphylaxis. The early phase typically peaks within five to thirty minutes and can escalate rapidly if the allergen dose is high or if cofactors are present.
Stage Four: The Late-Phase Reaction
Several hours after the initial burst, a second wave of immune activity often follows. Where the early phase is driven primarily by mast cell degranulation, the late phase involves the recruitment of additional inflammatory cells to the affected tissues. Eosinophils, basophils, neutrophils, and macrophages migrate to the reaction site, drawn by chemical signals called chemokines.8Oxford Academic (The Journal of Immunology). Eotaxin (CCL11) and Eotaxin-2 (CCL24) Induce Recruitment of Eosinophils, Basophils, Neutrophils, and Macrophages As Well As Features of Early- and Late-Phase Allergic Reactions Following Cutaneous Injection in Human Atopic and Nonatopic Volunteers
The late-phase reaction typically shows up four to eight hours after allergen exposure and can persist for a day or more. Symptoms are often different from the early phase: where the initial reaction might produce hives and throat tightness, the late phase often involves more diffuse swelling, prolonged gastrointestinal distress, nasal congestion, or lingering skin inflammation. Many people dismiss late-phase symptoms as unrelated to their earlier reaction, which can lead to underreporting. The late phase is not a new allergic event but the immune system’s ongoing processing of the initial trigger.
Stage Five: Biphasic Reactions
In some cases, a reaction appears to resolve, only for symptoms to return hours later with no new allergen exposure. These biphasic reactions are the most medically concerning of the later stages because they can catch people off guard after they believe the danger has passed. A large patient registry study found that roughly one in six food-allergic reactions was followed by a biphasic flare.9PubMed. Characterizing Biphasic Food-Related Allergic Reactions Through a US Food Allergy Patient Registry The risk was not evenly distributed: among people who had a very severe initial reaction, about 30% reported a biphasic event, compared with under 8% among those with mild initial symptoms.
Timing varies widely. A systematic review and meta-analysis across thousands of anaphylaxis patients found a median onset of about 11 hours for the second phase, with a range stretching from under 15 minutes to as long as 72 hours.10The Journal of Allergy and Clinical Immunology: In Practice. Time of Onset and Predictors of Biphasic Anaphylactic Reactions: A Systematic Review and Meta-analysis In a retrospective study of 202 anaphylaxis patients, about 9% experienced a biphasic reaction, with roughly three-quarters of those occurring within eight hours.11PubMed Central. Incidence and timing of biphasic anaphylactic reactions: a retrospective cohort study Interestingly, food as the inciting trigger was associated with a lower risk of biphasic reactions compared with other allergen types, though the risk was still meaningful enough to warrant extended observation after any serious reaction.12The Journal of Allergy and Clinical Immunology: In Practice. Time of Onset and Predictors of Biphasic Anaphylactic Reactions: A Systematic Review and Meta-analysis
Biphasic reactions are the reason emergency physicians often recommend observation periods of four to six hours (and sometimes longer) after treating anaphylaxis. The second wave can be milder than the first, or it can be equally severe. Predicting whether a biphasic reaction will occur remains difficult in any individual case, though more severe initial reactions and the presence of low blood pressure during the first phase are consistent risk factors.13PubMed. Characterizing Biphasic Food-Related Allergic Reactions Through a US Food Allergy Patient Registry
Why the Same Food Can Cause Different Reactions Every Time
A frustrating reality of food allergy is that reactions are not consistent. You might eat a trace of peanut one day and get mild hives, then eat a similar amount months later and end up in an emergency room. Cofactors play a large role in this unpredictability. Exercise, infections, anti-inflammatory drugs like ibuprofen, alcohol, and even sleep deprivation can all lower the threshold at which a reaction occurs or amplify its severity. These cofactors are estimated to play a role in roughly 30% of anaphylaxis reactions in adults.14PubMed. Cofactors in food anaphylaxis in adults
Some individuals tolerate a food allergen with no symptoms under resting conditions but react when they eat the same food and then exercise. Others tolerate the food alone and tolerate exercise alone, but the combination of both triggers anaphylaxis. In children, concurrent infections are especially well-documented cofactors.15PubMed Central. Food allergies and food-induced anaphylaxis: role of cofactors A child fighting a cold may react to a food they handled fine the previous week. This variability does not mean the allergy is imaginary or inconsistent; it means the immune threshold for degranulation shifts depending on the body’s overall inflammatory state.
Treatment Across the Stages
Because each stage involves different immune machinery, treatment priorities shift as a reaction progresses. In the early phase, epinephrine is the only first-line treatment for anaphylaxis. It works within minutes after intramuscular injection, constricting blood vessels, opening airways, and counteracting the cardiovascular collapse that makes anaphylaxis lethal. Antihistamines, despite being the medication most people reach for, cannot address the full range of mediators released during degranulation. They act much more slowly, reaching peak blood levels one to three hours after dosing compared with under ten minutes for injected epinephrine, and they do not reverse the airway obstruction, low blood pressure, or shock that define the most dangerous reactions.16PubMed. Optimal treatment of anaphylaxis: antihistamines versus epinephrine
Real-world data from a Canadian anaphylaxis registry reinforces this hierarchy. Patients who received epinephrine before arriving at the hospital were less likely to have uncontrolled reactions, less likely to need intravenous fluids, and less likely to be admitted. Prehospital antihistamines also showed some benefit for reducing uncontrolled reactions and admissions, but corticosteroids given before hospital arrival were actually associated with higher rates of IV fluid use and hospital admission, possibly because they were used preferentially in more severe cases or because they simply act too slowly to change acute outcomes.17PubMed. Managing anaphylaxis: Epinephrine, antihistamines, and corticosteroids: More than 10 years of Cross-Canada Anaphylaxis REgistry data
For the late phase and biphasic risks, ongoing observation and sometimes additional doses of epinephrine are the main strategies. There is no reliable way to pharmacologically prevent a biphasic reaction, which is part of why emergency observation periods exist.
The Gut Microbiome’s Influence on Sensitization
The composition of bacteria in the gut appears to influence whether the immune system’s first encounter with a food protein leads to tolerance or sensitization. Gut bacteria break down dietary fiber into short-chain fatty acids, which bind to receptors that help maintain gut barrier integrity, regulate inflammatory responses, and support the regulatory immune cells that keep allergic reactions in check.18PubMed. The nutrition-gut microbiome-physiology axis and allergic diseases When the gut microbial community is disrupted, these metabolites may be produced in insufficient quantities, potentially tipping the balance toward sensitization rather than tolerance.
This research is still in its early stages, but it offers a plausible connection between the modern rise in food allergies and changes in diet and antibiotic use that alter gut bacteria. High-fiber diets promote the bacteria that produce these protective metabolites, while low-fiber, highly processed diets may starve them. This does not mean fiber prevents food allergies in any straightforward way, but it does suggest that the conditions in which sensitization occurs are shaped by factors well upstream of the allergen itself.
How Diagnosis Is Evolving
Traditional allergy testing, whether skin prick tests or blood measurements of specific IgE, tells you whether sensitization has occurred but not necessarily whether you will react to the food. Many people test positive to a food they eat without any problem. This is why oral food challenges, where you eat gradually increasing amounts of a food under medical supervision, remain the gold standard for confirming a true food allergy. The problem is that food challenges are time-consuming, expensive, and carry risk.
Newer diagnostic approaches aim to close this gap. The basophil activation test measures how a patient’s basophils respond when exposed to an allergen in a blood sample. It has shown better specificity than skin prick testing and standard IgE measurements, meaning it is better at identifying who will truly react and who is merely sensitized. It can also track whether an allergy is resolving over time or responding to treatment.19PubMed Central. Road map for the clinical application of the basophil activation test in food allergy Meanwhile, component-resolved diagnosis tests for IgE against specific protein fragments within an allergen, which can help predict how severe a reaction might be and whether cross-reactivity with related foods is likely.20PubMed Central. Component resolved diagnosis and risk assessment in food allergy Both approaches are gradually moving from research settings into clinical practice, though neither has fully replaced standard testing yet.
Why IgE Exists in the First Place
It can seem like a design flaw that the body has an entire antibody class, IgE, devoted to causing reactions against harmless food proteins. But IgE did not evolve to make you allergic to shrimp. It evolved primarily as a defense against parasites and toxins, and the explosive mast cell response that characterizes food allergy is essentially a defense mechanism misfiring. The same rapid vomiting, diarrhea, and blood vessel permeability changes that make anaphylaxis dangerous are, in the right context, effective at expelling parasitic worms or flushing ingested toxins from the gut.
Researchers have argued that the allergic phenotype has likely saved far more mammalian lives over evolutionary time than it has cost, which is why IgE was preserved rather than selected out.21PubMed. The evolution of IgE-mediated type I hypersensitivity and its immunological value The mismatch between this ancient defense and modern life, where parasitic infections are rare and novel food proteins are abundant, helps explain why food allergy rates have climbed in industrialized countries. The immune system retains a powerful weapon it rarely gets to use for its intended purpose, and occasionally it fires at the wrong target.